the aid library

LIST OPTIONS

Filter

6789

Joint statement on infant and young child feeding in emergencies - Ethiopia, July 2021

FMOH, NDRMC, UNHCR, WHO, Unicef, WFP (2021) C_WHO

The Federal Ministry of Health of Ethiopia (FMOH), the National Disaster Risk Management Commission (NDRMC) and other government actors together with UN agencies (UNICEF, UNHCR, WHO and WFP) and nutrition development partners call for all parties involved in the response to emergencies in Ethiopia t... more

External Link

Whole of Syria Joint Statement: Protecting Maternal, Infant and Young Child Nutrition during the Earthquake response in Syria (12th of February 2023)

Nutrition Cluster; Save the Children; United Nation Children's Fund; World Health Organization (2023) CC

UNICEF, WHO Whole of Syria Nutrition, Cluster, the Global Nutrition Cluster, the IFE Core Group, and partners call for ALL involved in the response to the earthquakes in Syria to protect, promote, and support the feeding and care of infants and young children, their caregivers, especially pregnant, ... more

Download (134)

View PDF (137)

Integrating psychosocial interventions and support into HIV services for adolescents and young adults

World Health Organisation (WHO) (2023) C_WHO

Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio... more

Download (284)

View PDF (380)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (150)

View PDF (193)

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 2: NIPPV High-flow nasal oxygen (HFNO)
recommended

World Health Organization WHO (2022) C_WHO

For patients on HFNO with persistent hypoxaemia or respiratory distress: • Check the equipment: inspect the exterior of the machine, the tubing (circuit), the prong for any sign of mechanical damage, confirm it fits and the filters are in place. Ensure the settings are appropriate and flow is max... more

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 1: Characteristics of NIV
recommended

World Health Organization WHO (2022) C_WHO

WHO recommends prompt recognition of progressive acute hypoxaemic respiratory failure when a patient with respiratory distress is failing to respond to standard oxygen therapy and adequate preparation to provide advanced oxygen/ventilatory support. Hypoxaemic respiratory failure in ARDS commonly re... more

Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19: Recognize ARDS
recommended

World Health Organization WHO (2022) C_WHO

Download (328)

View PDF (217)

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation -Part 3: NIPPV (CPAP and BiPAP)
recommended

World Health Organization WHO (2022) C_WHO

For patients on NIPPV or HFNO with persistent hypoxaemia or respiratory distress: • Check the equipment: inspect the exterior of the machine, the tubing (circuit), the mask for any sign of mechanical damage, confirm it fits securely without leak (if CPAP/BiPAP) and the filters are in place. Ensur... more

Guía para el cuidado de pacientes adultos críticos con COVID-19 en las Américas. Versión 3

Organización Panamericana de la Salud OPAS (2021) C_WHO

Este documento incluye los resultados de un proceso de elaboración rápida de guías. La información incluida en esta guía refleja la evidencia a la fecha publicada en el documento. Las recomendaciones se basaron en la evidencia disponible y su calidad (metodología GRADE) en el momento en que s... more

Essential critical care skills 1: what is critical care nursing?

Credland, N.; et al. (2021) C2

Nursing Times [online]; 117: 11, 18-21.

Download (144)

View PDF (155)

Nurse practioner in critical care (Post Graduate-Residency Program)

Ministry of Health & Family Welfare ,India (2021) CC

Download (642)

View PDF (695)

Critical Care in Neurology

Kitchener – Hashem – Wahba – Khalaf – Zarif – Mansoor Flying Publisher (2012)

Competencies for critical care nurse specialist (Adult)

South African Nursing Council (2020) CC

Critical preparedness, readiness and response actions for COVID-19
recommended

World Health Organization WHO (2021) C_WHO

27 May 2021 All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public health scenarios, recognizing that there is no one-size-fits-all approach to managing cases and o... more

Download (179)

View PDF (170)

Critical considerations and actions for achieving universal access to sexual and reproductive health in the context of universal health coverage through a primary health care approach

World Health Organisation (WHO) (2023) C_WHO

The objective of Critical Considerations and Actions for Achieving Universal Access to Sexual and Reproductive Health in the Context of Universal Health Coverage through a Primary Health Care Approach is to provide guidance to WHO Member States for ensuring progress towards universal access to compr... more

External Link

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
recommended

Schieffelin, JS.; J.G. Shaffer; A. Goba, et al. (2014)

Guidelines for the managment of critical care

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Download (313)

View PDF (292)

Guidelines for the clinical management of severe illness from influenza virus infections

World Health Organization WHO (2022) C_WHO

Download (423)

View PDF (1042)

Critically important antimicrobials for human medicine

World Health Organization WHO (2017) C_WHO

5th revised edition. This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.

External Link

Critically important antimicrobials for human medicine: 6th Revision 2018

World Health Organization WHO (2018) C_WHO

The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ... more

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 2: NIPPV High-flow nasal oxygen (HFNO) recommended

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 1: Characteristics of NIV recommended

Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19: Recognize ARDS recommended

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation -Part 3: NIPPV (CPAP and BiPAP) recommended

Critical preparedness, readiness and response actions for COVID-19 recommended

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone recommended

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 2: NIPPV High-flow nasal oxygen (HFNO)
recommended

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 1: Characteristics of NIV
recommended

Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19: Recognize ARDS
recommended

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation -Part 3: NIPPV (CPAP and BiPAP)
recommended

Critical preparedness, readiness and response actions for COVID-19
recommended

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
recommended